Huvepharma Overview
- Year Founded
-
1954
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
14
Huvepharma General Information
Description
Manufacturer of human and animal health products based in Sofia, Bulgaria. The company focuses on developing, manufacturing and marketing animal and human health and nutrition products.
Contact Information
Website
www.huvepharma.com(Operating Subsidiary)
Corporate Office
- 3a, Nikolay Haytov Street
- 5th floor
- Sofia, 1113
- Bulgaria
Corporate Office
- 3a, Nikolay Haytov Street
- 5th floor
- Sofia, 1113
- Bulgaria
Huvepharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Huvepharma Comparisons
Industry
Financing
Details
Huvepharma Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Elanco Animal Health | Corporation | Greenfield, IN | ||||
Phibro Animal Health | Formerly PE-Backed | Teaneck, NJ | ||||
Parnell Pharmaceuticals Holdings | Corporation | Overland Park, KS | ||||
GlaxoSmithKline Pakistan | Corporation | Karachi, Pakistan | ||||
GSK | Corporation | Middlesex, United Kingdom |
Huvepharma Patents
Huvepharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4393494-A1 | Compound for use in the treatment and/or prevention of a clostridium difficile infection in a pig | Pending | 28-Dec-2022 | ||
GB-202101630-D0 | Coronaviridae infection and avermectins | Inactive | 05-Feb-2021 | ||
GB-202020611-D0 | Coronaviridae infection and avermectins | Inactive | 24-Dec-2020 | ||
GB-202009387-D0 | Coronaviridae infection and avermectins | Inactive | 19-Jun-2020 | ||
EP-3944736-A1 | Avermectins for use in treating coronaviridae infection | Inactive | 19-Jun-2020 | A61K31/7048 |
Huvepharma Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Glen Wilkinson | President & Chief Executive Officer, Huvepharma Inc USA | |
Kiril Domuschiev | President, Chief Executive Officer & Management Board Member | |
Maria Terzieva | Chief Financial Officer | |
Rafael Cabrera Ph.D | Director, Technical Services Swine | |
Anguel Jeliazkov | Vice President of Production |
Huvepharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Huvepharma Investments & Acquisitions (14)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Fermentalg | 18-Jun-2024 | Biotechnology | |||
Neovia (Animal Health Division) | 05-Sep-2018 | Other Consumer Non-Durables | |||
Hydromer (T-HEXX Animal Healthcare Business) | 28-Aug-2018 | Other Services (B2C Non-Financial) | |||
AgriLabs | 05-Jan-2018 | Animal Husbandry | |||
Corid | 27-Apr-2017 | Corporate Asset Purchase | Buildings and Property |
Huvepharma FAQs
-
When was Huvepharma founded?
Huvepharma was founded in 1954.
-
Who is the CEO of Huvepharma?
Glen Wilkinson and Kiril Domuschiev are the CEOs of Huvepharma.
-
Where is Huvepharma headquartered?
Huvepharma is headquartered in Sofia, Bulgaria.
-
What industry is Huvepharma in?
Huvepharma’s primary industry is Pharmaceuticals.
-
Is Huvepharma a private or public company?
Huvepharma is a Private company.
-
What is Huvepharma’s current revenue?
The current revenue for Huvepharma is
. -
How much funding has Huvepharma raised over time?
Huvepharma has raised $107M.
-
Who are Huvepharma’s investors?
Advance Properties and Citi Venture Capital International have invested in Huvepharma.
-
Who are Huvepharma’s competitors?
Elanco Animal Health, Phibro Animal Health, Parnell Pharmaceuticals Holdings, GlaxoSmithKline Pakistan, and GSK are some of the 10 competitors of Huvepharma.
-
When was Huvepharma acquired?
Huvepharma was acquired on 04-Sep-2024.
-
Who acquired Huvepharma?
Huvepharma was acquired by Olon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »